Understanding the Pathophysiology of Prurigo Nodularis (PN) and a Treatment Option for Appropriate PN Patients 18+ Years of Age
by Jonathan Silverberg, MD
Virtual (Zoom)
Learn more about the evolving understanding of the pathophysiology of prurigo nodularis (PN) and a treatment option that may help appropriate patients.
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Carsten Hamann, MD
Virtual (Zoom)
Learn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU), including its clinical manifestations, diagnostic evaluation, assessment scales, and a treatment option for appropriate CSU patients 12+ years…
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Marshall Shuler, MD
Virtual (Zoom)
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
A Treatment Option for Appropriate Patients With Skin Diseases Driven in Part by Type 2 Inflammation
by Timothy Patton, DO
Virtual (Zoom)
Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Amy Spizuoco, DO
Virtual (Zoom)
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Jared Jagdeo, MD
Virtual (Zoom)
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Adam Friedman, MD
Virtual (Zoom)
Learn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Gina Mangin, PA-C
Virtual (Zoom)
Learn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU), including its clinical manifestations, diagnostic evaluation, assessment scales, and a treatment option for appropriate CSU patients 12+ years of age.
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Zakiya Rice, MD
Virtual (Zoom)
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in driving this activity; and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.